Nephros Balance Sheet Health
Financial Health criteria checks 5/6
Nephros has a total shareholder equity of $8.2M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $10.4M and $2.2M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$2.46m |
| Equity | US$8.17m |
| Total liabilities | US$2.21m |
| Total assets | US$10.39m |
Recent financial health updates
Recent updates
It's A Story Of Risk Vs Reward With Nephros, Inc. (NASDAQ:NEPH)
Oct 03
We're Not Worried About Nephros' (NASDAQ:NEPH) Cash Burn
Jul 14Nephros, Inc. (NASDAQ:NEPH) Just Reported And Analysts Have Been Cutting Their Estimates
May 13After Leaping 40% Nephros, Inc. (NASDAQ:NEPH) Shares Are Not Flying Under The Radar
Dec 18At US$3.18, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?
Dec 14Nephros partners with Donastar and Tractor Beverage to supply and service nationwide fast-casual restaurant operation
Sep 28US$5.13: That's What Analysts Think Nephros, Inc. (NASDAQ:NEPH) Is Worth After Its Latest Results
Aug 13Market Sentiment Around Loss-Making Nephros, Inc. (NASDAQ:NEPH)
Mar 25At US$8.37, Is It Time To Put Nephros, Inc. (NASDAQ:NEPH) On Your Watch List?
Mar 04Announcing: Nephros (NASDAQ:NEPH) Stock Increased An Energizing 131% In The Last Five Years
Jan 28Nephros sees Q4 revenue in-line with estimates,
Jan 12Nephros, Inc. (NASDAQ:NEPH) Insiders Increased Their Holdings
Dec 08Nephros EPS beats by $0.02, misses on revenue
Nov 05Financial Position Analysis
Short Term Liabilities: NEPH's short term assets ($7.4M) exceed its short term liabilities ($1.1M).
Long Term Liabilities: NEPH's short term assets ($7.4M) exceed its long term liabilities ($1.2M).
Debt to Equity History and Analysis
Debt Level: NEPH is debt free.
Reducing Debt: NEPH has no debt compared to 5 years ago when its debt to equity ratio was 27.8%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NEPH has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: NEPH has less than a year of cash runway if free cash flow continues to grow at historical rates of 19.5% each year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/02 05:41 |
| End of Day Share Price | 2025/01/02 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nephros, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Robert Wasserman | Benchmark Company |
| Marc Wiesenberger | B. Riley Securities, Inc. |
| Anthony Vendetti | Maxim Group |